Life Biosciences

Mentioned in 6 analyzed podcast episodes across 5 shows

Mentioned On

This Week in Startups The Daily Moonshots with Peter Diamandis All-In with Chamath, Jason, Sacks & Friedberg The Human Upgrade: Biohacking for Longevity & Performance

Episode Mentions

This Week in Startups · Jul 22, 2026

Why this longevity startup raised in Japan, not Silicon Valley | TWiST Tokyo | E2315

“Dr. David Sinclair's company running the first clinical trial for a drug potentially reversing aging, expected 2026.”

Epigenetic methylation analysis for drug discoveryCell therapy manufacturing quality control using biomarkersJapan's Regenerative Medicine Act and regulatory fast-tracking

View Analysis

The Daily · May 17, 2026

Can We Reverse Aging?

“David Sinclair's biotech company with FDA approval for human trials using cellular rejuvenation to treat glaucoma and other eye diseases”

Cellular Rejuvenation TechnologyYamanaka Factors and Gene TherapyLongevity Science Research

View Analysis

Moonshots with Peter Diamandis · Apr 28, 2026

David Sinclair: The GLP-1 Side Effect No One Talks About, What AI Found in His Lab, and Reversing Blindness | Q&A EP #251

“Company developing ER100 therapy for reversing age-related diseases including macular degeneration and blindness”

GLP-1 drug side effects and safety monitoringAI-driven drug design and molecular screeningCellular reprogramming (OSK therapy)

View Analysis

Moonshots with Peter Diamandis · Apr 27, 2026

David Sinclair on the Longevity Pill, Age Reversal Timelines, and Updated Protocols | EP #250

“Company developing OSK gene therapy for epigenetic reprogramming; leading first human clinical trial for blindness cure”

Epigenetic Reprogramming Technology (OSK genes, Yamanaka factors)Gene Therapy Delivery Systems (AAV, lipid nanoparticles, chemical small molecules)Small-Molecule Drug Development for Longevity

View Analysis

All-In with Chamath, Jason, Sacks & Friedberg · Feb 28, 2026

Software Stocks Implode, Claude's Hit List, State of the Union Reactions, Trump's Tariff Pivot

“First company approved by FDA to test Yamanaka factors in humans for vision restoration”

AI disruption of software stocksAnthropic Claude market impactSaaS business model obsolescence

View Analysis

The Human Upgrade: Biohacking for Longevity & Performance · Feb 6, 2026

Biohackers in the Epstein Files, Generic GLP-1s, Continuous Ketone Monitors, and more... : 1411

“Received FDA clearance for first-in-human gene therapy trial using Yamanaka factors to reverse aging in retinal cells”

Gene Therapy for Age ReversalYamanaka Factors and Epigenetic ReprogrammingContinuous Ketone Monitoring Devices

View Analysis